Document Detail

A randomized trial of on-pump beating heart and conventional cardioplegic arrest in coronary artery bypass surgery patients with impaired left ventricular function using cardiac magnetic resonance imaging and biochemical markers.
MedLine Citation:
PMID:  18981306     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Beating heart coronary artery bypass grafting (CABG) improves early postoperative cardiac function in patients with normal ventricular function, but its effect in patients with impaired function is uncertain. We compared a novel hybrid technique of on-pump beating heart CABG (ONBEAT) with conventional on-pump CABG (ONSTOP) in patients with impaired ventricular function. METHODS AND RESULTS: In a single-center randomized trial, 50 patients with impaired ventricular function were randomly assigned to ONBEAT or ONSTOP. Patients underwent cardiac magnetic resonance imaging for function and delayed hyperenhancement early and later after surgery. Serial assessment of biochemical markers was also undertaken. Preoperative characteristics were well matched; cardiac index was 2.85+/-0.53 (ONBEAT) and 2.62+/-0.59 L x min(-1) x m(-2) (ONSTOP). Early after surgery, there was a trend toward a greater reduction in end-systolic volume index in ONSTOP patients versus ONBEAT (-9+/-8 versus -4+/-11 mL x m(-2); P=0.06). The changes were sustained and significant at 6 months (-14+/-18 versus -2+/-19 mL x m(-2); P=0.04). Furthermore, the incidence of new hyperenhancement at 6 days was higher in ONBEAT patients (P=0.05), with 6 of 17 (35%) sustaining 8.2+/-5.2 g of new hyperenhancement each versus 2 of 23 (9%) in the ONSTOP group, each with 9.8+/-9.0 g (P=0.86). Finally, median area under the curve for troponin was higher in ONBEAT at 461 (interquartile range, 226 to 1141) microg/L versus 160 (interquartile range, 98 to 357) microg/L for ONSTOP (P=0.002). CONCLUSIONS: The incidence of new irreversible myocardial injury was significantly higher in ONBEAT than in ONSTOP patients. Furthermore, at 6 months, only ONSTOP patients demonstrated an improvement in ventricular geometry. The most likely mechanism is inadequate coronary perfusion to distal myocardial territories in patients with severe proximal coronary disease.
Tammy J Pegg; Joseph B Selvanayagam; Jane M Francis; Theodoros D Karamitsos; Zoe Maunsell; Ly-Mee Yu; Stefan Neubauer; David P Taggart
Related Documents :
8269146 - Prognosis of valve replacement for aortic stenosis with or without coexisting coronary ...
7877226 - The effect of peripheral vascular disease on in-hospital mortality rates with coronary ...
16488676 - Use of bilateral internal thoracic arteries in cabg through lateral thoracotomy with ro...
17302686 - Clinical predictors of appropriate implantable-cardioverter defibrillator discharge.
8204236 - False negative transesophageal echocardiography in a patient with severe mitral regurgi...
2953226 - Myocardial protection by intracoronary nicardipine administration during percutaneous t...
Publication Detail:
Type:  Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't     Date:  2008-11-03
Journal Detail:
Title:  Circulation     Volume:  118     ISSN:  1524-4539     ISO Abbreviation:  Circulation     Publication Date:  2008 Nov 
Date Detail:
Created Date:  2008-11-18     Completed Date:  2008-12-09     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0147763     Medline TA:  Circulation     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2130-8     Citation Subset:  AIM; IM    
Department of Cardiology, Flinders Dr, Flinders Medical Centre, Bedford Park SA5042, Australia.
Data Bank Information
Bank Name/Acc. No.:
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Biological Markers / blood
Cardiac Output*
Coronary Artery Bypass / instrumentation,  methods*
Coronary Artery Disease / blood,  surgery*
Extracorporeal Circulation / methods*
Magnetic Resonance Imaging*
Middle Aged
Time Factors
Ventricular Dysfunction, Left / blood,  surgery*
Grant Support
PG/05/037//British Heart Foundation
Reg. No./Substance:
0/Biological Markers

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Exercise-induced pulmonary arterial hypertension.
Next Document:  Aliskiren accumulates in Renin secretory granules and binds plasma prorenin.